Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001877813 | SCV002141122 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2022-08-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002552139 | SCV003725658 | uncertain significance | Inborn genetic diseases | 2022-09-30 | criteria provided, single submitter | clinical testing | The c.1607C>T (p.P536L) alteration is located in exon 9 (coding exon 8) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 1607, causing the proline (P) at amino acid position 536 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003395252 | SCV004133630 | uncertain significance | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing |